Clinical Trial Update: Study of Memantine for Gait Disorders And Attention Deficit In Parkinson's Disease [Phase 4]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 4 study evaluating memantine for gait disorders and attention deficits in Parkinson's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gait Disorders
• Parkinson Disease

Drugs mentioned

• Memantine (memantine)

Snippet

Sponsor: University Hospital, Lille | Conditions: Parkinson's Disease, Gait Disorders, Neurologic | Phase 4 | Status: COMPLETED